Form D · Pharmaceuticals

PAION AG

Aachen, 2M · CIK 0001594923

Offering snapshot reported Jul 18, 2014 · SEC filing

Reported sold
$6.75M
Offering amount: $6.75M
Investors reported
9
Form D · investor count
Minimum accepted
$3
Reported outside-investor minimum
First sale
Jul 4, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 18, 2014Initial$6,745,985No comparison9SEC filing
Feb 20, 2014Initial$4,349,671No comparison1SEC filing
Jan 27, 2014Initial$4,097,400No comparison1SEC filing
Jan 15, 2014Amendment$820,697-$2,826,413vs Jan 2, 20141SEC filing
Jan 2, 2014Initial$3,647,110No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06c
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$225K
Form D file number
021-221358
Based on the exchange rate of EUR 1 = USD 1.3598
Based on the exchange rate of EUR 1.00 = USD 1.3598

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Trout Capital LLC131489

Source: Form D, filed Jul 18, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Wolfgang Soehngen Director, Executive
Mariola Soehngen Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
Martinstrasse 10 12
Aachen, 2M, 52062